Research Study

A Phase II, Open-Label Exploratory Study Investigating the Efficacy of Toviaz for Treatment of Adult Patients With Spinal Cord Injury With Neurogenic Detrusor Overactivity for Amelioration of Autonomic Dysreflexia (PIIR-AK-TOVIAZ-AD)
Principal Investigator 
Andrei Krassioukov

Overview

Body Locations and Systems 
ClinicalTrials.gov# 
NCT02676154
Status 
Recruiting
Study Start/End 
Nov 30, 2015 to Jun 30, 2018
Locations 
GF Strong Rehabilitation Centre, ICORD – Blusson Pavilion, UBC Hospital
Name/Title 
Andrei Ramirez, Study Coordinator
Phone 
604-675-8856
Email Address 
aramirez@icord.org
Purpose of Study 

This study will be investigating the effects of fesoterodine on autonomic dysreflexia (AD) in patients with spinal cord injuries (SCI). The goal of the study is to examine the effect of increasing daily use of fesoterodine on episodes of high blood pressure triggered by urinary bladder contractions.

recruitment poster

Eligibility 

Visit ClinicalTrials.gov for more information.

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific clinical research trials only. If you have specific questions which require clinical expertise, please call your primary care physician.